These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15084442)

  • 81. Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethorphan-induced seizure protection.
    Tortella FC; Ferkany JW; Pontecorvo MJ
    Life Sci; 1988; 42(24):2509-14. PubMed ID: 3374269
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Calcium channel agonist, (+/-)-Bay K8644, causes a transient increase in striatal monoamine oxidase activity in Balb/c mice.
    Samantaray S; Chandra G; Mohanakumar KP
    Neurosci Lett; 2003 May; 342(1-2):73-6. PubMed ID: 12727321
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Brain activation pattern induced by stimulation of L-type Ca2+-channels: contribution of Ca(V)1.3 and Ca(V)1.2 isoforms.
    Hetzenauer A; Sinnegger-Brauns MJ; Striessnig J; Singewald N
    Neuroscience; 2006; 139(3):1005-15. PubMed ID: 16542784
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Expression of c-FOS in the brain after activation of L-type calcium channels.
    Jinnah HA; Egami K; Rao L; Shin M; Kasim S; Hess EJ
    Dev Neurosci; 2003; 25(6):403-11. PubMed ID: 14966381
    [TBL] [Abstract][Full Text] [Related]  

  • 85. New treatment methods in verapamil poisoning: experimental studies.
    Magdalan J
    Pol J Pharmacol; 2003; 55(3):425-32. PubMed ID: 14506322
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat.
    Wu D; Otton SV; Kalow W; Sellers EM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1431-7. PubMed ID: 7562518
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The effects of chronic treatment with the dihydropyridine, Bay K 8644, on hyperexcitability due to ethanol withdrawal, in vivo and in vitro.
    Whittington MA; Butterworth AR; Dolin SJ; Patch TL; Little HJ
    Br J Pharmacol; 1992 Feb; 105(2):285-92. PubMed ID: 1373096
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Induction of phencyclidine-like behavior in rats by dextrorphan but not dextromethorphan.
    Székely JI; Sharpe LG; Jaffe JH
    Pharmacol Biochem Behav; 1991 Oct; 40(2):381-6. PubMed ID: 1805242
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dextromethorphan inhibits but dextrorphan potentiates behavior induced by PCP and ketamine in rats.
    Székely JI; Sharpe LG; Jaffe JH
    NIDA Res Monogr; 1990; 105():341-4. PubMed ID: 1876034
    [No Abstract]   [Full Text] [Related]  

  • 90. Ginsenoside Re blocks Bay k-8644-induced neurotoxicity via attenuating mitochondrial dysfunction and PKCδ activation in the hippocampus of mice: Involvement of antioxidant potential.
    Tran NKC; Jeong JH; Sharma N; Nguyen YND; Tran HP; Dang DK; Park JH; Byun JK; Jin D; Xiaoyan Z; Ko SK; Nah SY; Kim HC; Shin EJ
    Food Chem Toxicol; 2023 Aug; 178():113869. PubMed ID: 37308051
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Attenuation of the stimulant and convulsant effects of cocaine by 17-substituted-3-hydroxy and 3-alkoxy derivatives of dextromethorphan.
    Zapata A; Gasior M; Geter-Douglass B; Tortella FC; Newman AH; Witkin JM
    Pharmacol Biochem Behav; 2003 Jan; 74(2):313-23. PubMed ID: 12479950
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Anticonvulsant effects of the BK-channel antagonist paxilline.
    Sheehan JJ; Benedetti BL; Barth AL
    Epilepsia; 2009 Apr; 50(4):711-20. PubMed ID: 19054419
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antitussive activity and other related pharmacological properties of d-3-methyl-N-methylmorphinan (AT-17).
    Kasé Y; Kito G; Miyata T; Uno T; Takahama K; Ida H
    Arzneimittelforschung; 1976; 26(3):353-60. PubMed ID: 989326
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Functional implication of calcium ions in epileptic seizures. Antiepileptic effects of organic calcium antagonists].
    Speckmann EJ; Walden J; Bingmann D
    Arzneimittelforschung; 1989 Jan; 39(1A):149-56. PubMed ID: 2655613
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evaluation of dextromethorphan and carbetapentane as anticonvulsants and N-methyl-D-aspartic acid antagonists in mice.
    Leander JD
    Epilepsy Res; 1989; 4(1):28-33. PubMed ID: 2666123
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The nonnarcotic antitussive drug dimemorfan: a review.
    Ida H
    Clin Ther; 1997; 19(2):215-31. PubMed ID: 9152562
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat.
    Morón MA; Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1150-5. PubMed ID: 2319465
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Plasma-polymerized membrane electrode for the determination of dextromethorphan and dimemorfan.
    Hazemoto N; Ishizaka S; Haga M; Kato Y; Kurosawa S; Kamo N; Kobatake Y
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2153-4. PubMed ID: 2598314
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Altered behavioral sensitivity of Ca(2+)-modulating drugs after chronic nicotine administration in mice.
    Damaj MI
    Eur J Pharmacol; 1997 Mar; 322(2-3):129-35. PubMed ID: 9098679
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Self-biting induced by activation of L-type calcium channels in mice: dopaminergic influences.
    Kasim S; Jinnah HA
    Dev Neurosci; 2003; 25(1):20-5. PubMed ID: 12876427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.